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Abstract 
Recently, the field of bionanotechnology has sought to develop a device containing a 
biomolecular motor nano-cargo transport system. Among many applications, a device of this sort 
could be used to sort, purify, or detect specific molecules. In this work, an attempt was made to 
incorporate the actin-myosin biomolecular motor system into a microfluidic device constructed 
out of polydimethylsiloxane (PDMS) and glass. Methods for cleaning and functionalizing the 
glass surface of the device were optimized. After performing actin-myosin motility assays in a 
variety of PDMS/glass devices, it was determined that the oxygen permeability of PDMS limited 
the quality of motility that could be obtained upon illumination. Heavy treatment (20 minutes) of 
the PDMS surface with an air plasma allowed for more prolonged motility. More efforts to 
reduce the permeability of PDMS and improve motility will have to be made before a functional 
device can be achieved. 
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Background 
Biomolecular motors are enzymes that convert chemical energy into mechanical energy, 
typically by using adenosine triphosphate (ATP) as fuel. ATP hydrolysis is used to drive many 
biological processes because it is a highly exergonic reaction. There are several different 
biomolecular motors found in eukaryotic cells, including linear and rotary types. Myosin, 
kinesin, and dynein are examples of linear molecular motors, which use the energy from ATP to 
achieve a net displacement1. The main focus of this paper will be a system containing the myosin 
motor. 
Myosins are molecular motor proteins that bind actin filaments and use ATP to fuel a 
conformational change, allowing actin to slide relative to the myosin. Biologically, they have a 
large role in muscle contraction, as well as intracellular cargo transport. There are several types 
of myosin; at least 18 classes were known in 20062. The basic structure of myosin consists of a 
heavy polypeptide chain with a globular head and a tail. Often, other light chains are attached to 
the head. The tails of two heavy chains wrap around each other in a coil to form dimers in types 
such as myosin II and myosin V2. The process of ATP hydrolysis for most types of myosin is 
quite similar; however, some other features vary among the different types. Myosin II is referred 
to as conventional myosin and is found in skeletal, heart, and smooth muscle cells, along with 
nonmuscle cells2. The investigation of muscle myosin began in 18643 and still continues to this 
day. At physiological ionic strengths, myosin is insoluble4. However, using tryptic digestion, 
myosin can be progressively cleaved to generate fragments that are soluble. With low exposure 
to trypsin, myosin II can be cleaved into light meromyosin (LMM) and heavy meromyosin 
(HMM). HMM consists of a truncated coiled-tail portion with the two globular heads still intact 
(Figure 1). Further cleavage can separate the two heads from the remaining tail portion. The head 
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portion is referred to as subfragment-1 (S1)2. Both the nucleotide- and actin-binding regions are 
found on the myosin head, although located on opposite sides5. 
 
 
 
 
 
 
 
Figure 1. Schematic of a myosin II molecule. 
 
Actin is also present in muscle fiber and is a major component of the cytoskeleton in 
eukaryotic cells6. Actin filaments (F-actin) are helically-shaped strands of G-actin (globular 
actin) monomers with approximately a 7 nanometer diameter (Figure 2). Each G-actin is added 
to the strand in the same orientation, creating polarity in the filament2. Under cellular conditions, 
G-actin and F-actin exist in similar quantities. To achieve polymerization of actin in vitro, 
physiological ionic strength conditions must be used7. To stabilize the filaments and guard 
against depolymerization, phalloidin, a toxic component of Amanita phalloides, is added in 
vitro8. Actin filaments can also be bundled in vitro using the bundling protein fascin.     
 
 
 
Figure 2. Schematic of an actin filament. The black and gray coloration depicts the two helical 
strands of G-actin monomers (represented by individual spheres) that are coiled together to form 
F-actin.  
S1 
HMM LMM
7 nm 
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In 1986, Kron and Spudich developed an in vitro motility assay for the actin-myosin 
system9. Using fluorescence microscopy, fluorescently labelled actin filaments could be 
visualized moving across a glass surface coated with myosin filaments. Over time, many 
improvements and modifications to the assay have been made. Myosin fragments such as HMM 
are frequently used in in vitro motility assays now (see Figure 3). Actin bundles made using 
fascin have been shown to exhibit the same sliding velocity in vitro as actin filaments, while 
providing greater rigidity10. It has also become standard for the glass surface to be coated with 
nitrocellulose prior to HMM binding to enhance motility. However, trimethylchlorosilane 
(TMCS)-derivatized glass surfaces have been shown to support actin-myosin motility as well or 
better than the standard nitrocellulose surfaces11. Figure 4 shows the reaction of TMCS with free 
hydroxyl groups on a clean glass surface, which creates trimethylsilyl groups. These groups are 
thought to promote the adsorption of HMM molecules in orientations that support motility12.  
 
 
  
 
 
 
Figure 3. Schematic of an actin-myosin in vitro motility assay. HMM molecules are attached to 
a modified glass surface (nitrocellulose-coated or functionalized with trimethylsilyl groups). The 
remaining glass surface is blocked with bovine serum albumin (BSA) before the addition of 
actin. When ATP is introduced, it is hydrolyzed by the myosin heads, resulting in a 
conformational change which propels the actin forward. 
Actin
Glass  Nanodevice FloorGlass Surface
ATP
ADP + Pi
HMM
BSA
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Figure 4. Reaction of TMCS with hydroxyl groups on a glass surface to produce a surface 
functionalized with trimethylsilyl (TMS) groups. 
 
Introduction 
Due to the ease with which motility can be achieved in vitro using biomolecular motors, 
there has been much interest during recent years in incorporating these motors into the growing 
field of nanotechnology for cargo transport applications. In order to facilitate any type of 
transport system, including those on the molecular level, several essential components are 
required. In this case, myosin or kinesin molecules function as the motor and ATP is the fuel 
source. It is also necessary to have a “road” or guide for direction of filament or microtubule 
movement, a method for starting and stopping, and a way to load and unload their cargo. 
Several methods for confining the motile components of the system (actin filaments or 
microtubules) and directing their motion have been used in past studies. Two of the most 
commonly used methods are chemical13,14 and topographical patterning of surfaces15-20. 
Chemical patterning typically results in varying surface hydrophobicity, where some regions of 
the surface favor adsorption of the motor protein over other regions. Topographical patterning 
can be achieved using direct lithography techniques15,16,18,19 or replica molding17,20. In some 
cases, chemical and topographical patterning methods are used together. A few groups have also 
used enclosed channels for confinement of microtubules21-23. To more specifically guide filament 
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or microtubule motion, some techniques such as PMMA gratings24 and electric fields22,24 have 
been developed. Unidirectional motion of microtubules has been achieved with directional 
rectifiers resembling arrowheads or heart-shapes16,25.  
There are also a few different approaches to starting and stopping filament or microtubule 
movement. Stoppage can occur due to a lack of ATP or by the inhibition of the hydrolysis of 
ATP. Introduction of caged ATP into the motility assay has resulted in cycles of starting and 
stopping microtubules by using UV light exposure to release a portion of the ATP17. The 
microtubules begin to move at a high velocity and gradually slow to a stop when the ATP is used 
up, at which point another exposure to UV light is necessary to start the movement again. 
Blebbistatin has also been used to manipulate myosin ATPase activity in motility assays26,27. 
Blebbistatin is a small-molecule, high-affinity, noncompetitive inhibitor specific for most forms 
of myosin II28 and can be photoinactivated by illumination with “blue” light26, allowing for 
reversible starting and stopping. A different method of control uses a dendrimer with peripheral 
guanidinium ions that has been found to inhibit motility of actin by preventing dissociation of the 
actomyosin complex29. This effect was also found to be reversible, with motility resuming after 
washing the flow cell with ATP buffer. In another study30, removal of antioxidants (the glucose 
oxidase-catalase system) and reducing agents [dithiothreitol (DTT)] from the motility buffer 
caused motility to cease, with motility resuming after the components were re-introduced. This 
behavior was thought to be due to a reversible oxidative modification of the myosin structure, 
most likely a disulfide bond.  
Biomolecular motor systems have been successful at carrying several different types of 
cargo, and some methods for loading and unloading cargo have been developed. Streptavidin-
coated quantum dots have been transported by actin filaments31. Actin bundles have been used to 
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carry streptavidin- and biotin-coated beads27, liposomes32, and E. coli cells32. Microtubules 
labeled with single-stranded DNA have been able to load and unload polystyrene beads33, 
quantum dots33, gold nanoparticles34, and liposomes35 labeled with complementary single-
stranded DNA.  
Combining all of these features into one integrated microfluidic device, containing 
channels with measurements of width and height that are on the order of microns, could provide 
the best means to both confine the biomolecular motor system and incorporate a method for 
starting and stopping, as well as loading and unloading cargo. Incorporating biomolecular motors 
into microfluidic devices for use with cargo transport could enable the production of new 
analytical devices that operate on a very small scale36. The small dimensions of these devices can 
yield several benefits, including: lower production and usage costs, smaller quantities of reagents 
and analytes, shorter analysis time, and less waste37. Using biomolecular motors for 
nanotechnology applications within a microfluidic device has several advantages. Typically 
when chemical patterning techniques are used to contain the motor system, the motor protein 
favors adsorption to only one portion of the pattern, restricting motility to that area. However, 
because physical barriers are not present, the filaments or microtubules are free to fall off the 
edge of the track or diffuse away. When topographical patterning is used, motility is often in a 
recessed track with walls that act as physical barriers and aid in the containment, but some 
filaments or microtubules may still climb the walls and be lost. In a microfluidic device, the 
walls and ceiling of the small channels act as barriers to completely contain the filaments or 
microtubules. It is also possible to create a wide variety of microfluidic channel designs that suit 
specific needs. Additionally, because there are methods to seal the device, it could be possible 
for the device to be stored without loss of function of the proteins.  
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Motility of microtubules over a kinesin-coated surface has been achieved in enclosed 
microfluidic channels21-23, but to our knowledge, no one has successfully introduced the actin-
myosin system into an enclosed channel. In this work, we have sought to incorporate the actin-
myosin biomolecular motor system into a device containing PDMS/glass microfluidic channels. 
The parameters that must be changed and/or optimized when transitioning from the glass flow 
cell used in standard motility assays to a microfluidic device, as seen in Figure 5, have been 
addressed. 
 
 
 
 
 
 
 
 
Figure 5. Comparison of a standard flow cell and a rudimentary microfluidic device. 
 
Experimental Methods 
Materials 
HMM, actin acetone powder, fascin, glucose, glucose oxidase, catalase, and ATP were 
obtained from Dr. Eric Blough’s lab. Sodium bicarbonate (Sigma-Aldrich) and potassium 
chloride (Sigma Chemical Company) were purchased. An Eppendorf Refrigerated Centrifuge 
5403 and a Beckman Optima LE-80K Ultracentrifuge were used in making F-actin. Rhodamine 
phalloidin from Invitrogen (Molecular Probes R415) and Cytoskeleton (PHDR1) was used to 
Standard Flow Cell Microfluidic Device
Glass Slide PDMS 
Microfluidic 
Channel 
Double-Sided Tape 
Nitrocellulose-Coated 
Glass Coverslip 
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label F-actin. A Thermo Spectronic Genesys 10 Vis spectrophotometer was used to perform 
Bradford assays. Imidazole (99+%, crystalline) from Acros Organics was a motility buffer 
component. FisherFinest Premium Cover Glasses (18mm x 18 mm, No. 1) or Fisherbrand 
Microscope Cover Glass (18mm x 18mm, No.2) from Fisher Scientific, Pearl frosted microscope 
slides from T&Q Industries, and NICETACK 15mm x 20m double-sided tape (NW-15) from 
Nichiban were used to construct flow cells. 2% collodion (in isoamyl acetate) and isoamyl 
acetate (98%) from Sigma-Aldrich were used to create nitrocellulose-coated cover glass. 
Coomassie (Bradford) Protein Assay Reagent and Albumin (BSA) Standard Ampoules (2 
mg/mL) were purchased from Thermo Scientific. Methylcellulose was purchased from Fisher 
Science Education.  
A Sylgard 184 Silicone Elastomer Kit from Dow Corning Corporation containing 
Sylgard 184 Silicon Elastomer Base and Sylgard 184 Silicon Elastomer Curing Agent was used 
to make PDMS. Silica wafers with SU-8 photoresist patterns were ordered from the Stanford 
Microfluidics Foundry as master molds. A punch (CR0350255N20R4) was purchased from 
Technical Innovations for punching input holes in PDMS. Dichloromethane (Macron 
Chemicals), pentane (Fisher Scientific), and toluene (EMD Chemicals) were all used for 
removing contaminants from PDMS. Fisherbrand Microscope Cover Glass (24mm x 40mm, No. 
2) was used as the floor of the device. Ethyl alcohol (200 Proof) from PHARMCO-AAPER and 
isopropanol (Acros Organics) were used for cleaning PDMS and glass. Concentrated sulfuric 
acid (Fisher Scientific) and hydrogen peroxide (35 wt.% in water) from Acros Organics were 
used to make piranha solution for cleaning glass. A plasma cleaner (SN: PDC32G1051452) was 
purchased from Harrick Plasma. TMCS from Thermo Scientific and 3-
aminopropyltrimethoxysilane (Aldrich) were used for functionalizing glass surfaces. A Pacific 
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Nanotechnology Nano-R AFM was used to study the glass surfaces. EZ-Link® Sulfo-NHS-LC-
Biotin was purchased from Thermo Scientific.  
A Cheminert six-port injector from VICI, a KD Scientific single syringe infusion pump 
(KDS100), and a KD Scientific two syringe infusion pump (KDS200) were used to introduce 
solutions into the device. A 25 µL Hamilton syringe was purchased to inject solutions. Stainless 
steel tubes (0.025” OD x 0.017” ID x 0.500” long) were purchased from New England Small 
Tube Corporation. A Nikon Diaphot 300 microscope, an Olympus UVFL100 objective, and a 
Hamamatsu Orca-R2 digital CCD camera were used for imaging. 
Standard Actin Motility Assay 
 Prior to proceeding with experiments to obtain actin motility in a microfluidic channel, a 
positive control for actin motility had to be established. Imidazole buffer (25 mM imidazole, 25 
mM KCl, 2 mM MgCl2, 0.2 mM CaCl2, pH: 7.0) was made for use as the motility buffer. F-actin 
was obtained by polymerization of G-actin using a standard protocol (see Appendix A-I). F-actin 
was also labeled with rhodamine phalloidin for stabilization and visualization (Appendix A-II).  
If desired, actin was bundled using the protein fascin (Appendix A-III). HMM was obtained, and 
a Bradford assay was performed to determine concentration (Appendix A-IV). A flow cell was 
constructed out of a glass slide and a nitrocellulose-coated coverslip, and standard motility assay 
procedures were followed (Appendix A-V). Standard motility assays were performed at regular 
intervals to ensure that HMM was active and that good actin motility could be visualized.   
Designing Microfluidic Masters 
AutoCAD 2007 and AutoCAD 2012 were used to create microfluidic channel designs 
(Figure 6). Figure 6–A is a simple design of two perpendicular channels forming an intersection. 
Figure 6–B is a modified “Y”-shaped design meant for establishing laminar flow with three 
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inputs and one output. A gradient of several straight channels with widths ranging from 400 µm 
to 1000 µm (Figure 6–D) was designed to investigate the influence of the flow velocity inside 
the microfluidic channel on obtaining actin motility. Figures 6–C, 6–E, and 6–F are all 
combinations of Figures 6–A and 6–B. As the most complex design, it was created for 
experiments investigating starting and stopping actin motility inside a microfluidic device.    
 
 
Figure 6. AutoCAD 2007 (top) and AutoCAD 2012 (bottom) designs for photoresist masters 
used to create microfluidic channels in PDMS. 
 
 
The designs were sent to the Stanford Microfluidics Foundry to create masters (silicon 
wafers with SU-8 photoresist patterns). A photomask was created by printing the desired design 
on transparency film using a high resolution printer (20,000 dpi). SU-8 photoresist was spin-
coated onto a silicon wafer, and the photomask was placed over the wafer. The photoresist was 
then exposed to UV light, but only in the areas where the photomask was transparent. In the case 
of SU-8, a negative photoresist, the UV light exposure caused cross-linking. In the regions where 
SU-8 was not exposed to UV wavelengths, the SU-8 was removed with a developer solution.  
This procedure resulted in raised channel features, which can be used to mold PDMS.  
A B C 
D E F 
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Figure 7. Steps for creating a photoresist master using photolithography.  
 
Making PDMS Molds 
 To make the PDMS portion of the device, Sylgard 184 Silicone Elastomer Base and 
Sylgard 184 Silicone Elastomer Curing Agent were mixed in a 10:1 ratio by mass. A vacuum 
desiccator was used to remove gas from the mixture. The pre-polymer mixture was poured over a 
master in a Petri dish and placed in a 75°C oven for about two hours. The mold was removed 
from the Petri dish and separated from the master. Using a punch housed by a drill press, holes 
were punched in the PDMS to create inputs for external tubing. To remove remaining pre-
polymer components, the mold was sonicated in a solvent that swelled the PDMS (i.e. toluene, 
methylene chloride, pentane), followed by a solvent that allowed the PDMS to return to its 
original shape (i.e. ethanol or isopropanol). In early experiments, molds were sonicated in 
AutoCAD file
High resolution printing
Photolithography
Developing
Photomask
Photoresist
on Si wafer
Master
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toluene two times for at least five minutes, then in ethanol or isopropanol two times for at least 
five minutes. In later experiments, 5 minute sonications in methylene chloride, pentane, and 
isopropanol were performed, in that order, and the cycle was completed three times. This 
technique was based on the procedure of Runge et al.38, in which methylene chloride and 
pentane were used to remove remaining platinum catalyst. After the washing steps, the PDMS 
mold was placed in a 75°C oven overnight to remove any remaining solvent.   
Cleaning Glass Surfaces 
 In order to clean the glass surface of the device, it was rinsed with water, sonicated in 
ethanol or isopropanol for at least five minutes, and dried with nitrogen gas. The glass was 
placed in a plasma cleaner for one minute at about 200 mtorr for additional cleaning.  
Alternatively, the glass was sonicated in deionized water for at least five minutes, and then 
cleaned in piranha solution (concentrated sulfuric acid and 30% H2O2 in a 7:3 ratio) for one hour. 
Caution: piranha solution is a highly corrosive acidic solution that can react violently with 
organic materials. Do not store in a closed container, and use appropriate safety precautions. 
When removed from the piranha solution, the glass was rinsed with deionized water and dried 
with nitrogen gas. 
Atomic Force Microscopy of Cleaned Surfaces and Image Analysis 
Glass coverslips were cleaned using variations of the two methods described above. One 
coverslip was rinsed with water, sonicated in ethanol, rinsed with isopropanol, and dried with 
nitrogen gas. Another was soaked in piranha solution (7:3 ratio of concentrated sulfuric acid : 
30% hydrogen peroxide) for one hour, rinsed with deionized water, and dried with nitrogen gas.  
Surfaces were imaged using a Pacific Nanotechnology Nano-R AFM. A tapping mode 
probe made of single crystal silicon with a radius of less than 10 nm was used. The working 
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frequency range for the tip was 200-400 kHz. To obtain an AFM image, the laser was aligned 
with the tip and the detector. A frequency sweep was performed to identify the resonance 
frequency for the tip. The tip was brought into feedback with the sample, and the setpoint and 
gain settings were modified to produce an acceptable line scan. A 20x20 µm2 scan was taken of 
each surface. The scan rate was 1 Hz and the resolution was set to 512 pixels x 512 pixels for all 
scans collected. 
Images were analyzed using Pacific Nanotechnology Nanorule+ software. Multiple 
leveling steps were performed on each image due to tilt and bowing that were introduced by the 
scanner. 1st order, 2nd order, and 3rd order 1D horizontal leveling were performed, followed by 
1st order, 2nd order, and 3rd order vertical leveling. If large particles were visible in the image, 
these were excluded prior to each leveling. Surface roughness measurements were then taken for 
the images. Particle counts were performed using ImageJ software. The threshold for each image 
was set at the pixel intensity corresponding to 3 nanometers above the intensity value at the 
maximum of the image’s histogram. Each image was converted to a binary image and the 
“Analyze Particles” function was used to obtain the particle count.  
Functionalizing the Glass Surface of a Microfluidic Device 
Glass surfaces were functionalized with either 3-aminopropyltrimethoxysilane or TMCS. 
To functionalize a clean glass coverslip with 3-aminopropyl-trimethoxysilane, the glass was 
placed inside a glass jar along with an aluminum foil “bowl” containing two to three drops of the 
amine-terminated silane. The lid was sealed, and the jar was placed in a 100°C oven for one 
hour. The surface was rinsed with ethanol and water following deposition. The same method was 
used to functionalize the glass surface with TMCS. To test the covalent bonding between glass 
functionalized with each silane and PDMS, a PDMS surface was activated by a plasma cleaner, 
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placed in contact with the functionalized glass, and heated in a 75°C oven for at least 15 minutes. 
After removal from the oven, tweezers were used to attempt to remove the PDMS from the glass 
surface in order to test the strength of the bond formed, if any. Actin-myosin motility assays 
were also performed using both treated surfaces. 
In order to perform functionalization of microfluidic channels after a device had been 
constructed, the vapor deposition method outlined above was modified. TMCS vapor was drawn 
from the headspace of a vial containing a few drops of liquid TMCS, and then introduced into 
the microfluidic channel, which was plugged to contain the TMCS vapor. Actin-myosin motility 
was performed on coverslips functionalized by vapor depositing TMCS in a similar way to 
determine the amount of time needed for deposition. Solution deposition of TMCS was also 
investigated by attempting functionalization of glass coverslips with TMCS in either water or 
ethanol. Different concentrations of TMCS in ethanol (1%, 2% and 5%) were used to treat glass 
surfaces, which were tested with the standard actin motility assay. In all further experiments with 
functionalized glass, the microfluidic channels were incubated with a solution of 5% TMCS in 
ethanol for 15 minutes immediately after the device was constructed.  
Constructing Microfluidic Devices 
To bond the PDMS and glass together in our initial hybrid microfluidic device, a plasma 
cleaner was used to oxidize the surface of the PDMS with the channel molds. If glass was 
cleaned with piranha solution immediately prior to this step, no plasma treatment of the glass 
was necessary. Otherwise, the glass was also placed in the plasma cleaner. The surfaces were 
placed face up in the plasma chamber and treated with a plasma created with room air at about 
200 mtorr for 20 to 40 seconds. The surfaces were then removed and placed in contact with one 
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another immediately. Pressure was applied to ensure that the entire surface was in contact. The 
device was placed in a 75°C oven for at least 15 minutes to help strengthen the bond. 
 
 
 
 
 
 
 
 
 
Figure 8. Chemical reactions involved in bonding PDMS to glass. 
  
After a lack of motility in the initial microfluidic devices, a new method for constructing 
the devices was developed. After the washing procedures described earlier, the PDMS mold was 
placed channel-side up in a plasma cleaner and treated for 20 minutes. Additional PDMS pre-
polymer was mixed and spin-coated on a silica wafer (approximately 80 µL, ramped at 500 
rpm/sec to a speed of 7000 rpm/sec for 5 minutes). The PDMS mold was stamped against the 
silica wafer so that the surface was evenly coated with pre-polymer. The PDMS mold was 
carefully lifted up and placed on a piranha-cleaned glass coverslip. The device was placed in a 
75°C oven for about 1 hour.    
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Figure 9. Microfluidic device constructed using a PDMS “glue” layer. 
 
Actin Motility Assay in a PDMS/Glass Flow Cell 
 The standard motility assay flow cell described above was modified so that a PDMS slab 
replaced the glass slide used to construct the cell. Experiments were performed with hydrophilic 
PDMS (treated with an air plasma for 40 seconds), functionalized PDMS (treated with an air 
plasma and exposed to TMCS), and PDMS with reduced oxygen permeability (treated with an 
air plasma for 20 minutes). Both nitrocellulose-coated coverslips and TMCS-treated coverslips 
were used as motility surfaces with this type of flow cell. The standard motility assay protocol 
was followed (Appendix A-V). Methylcellulose (0.3% - 0.6%) was included in the ATP solution 
for these experiments.  
Actin Motility Assay in a Modified Microfluidic Device 
 A PDMS mold with channels was trimmed in such a way that one end was cut off of each 
channel, leaving one open end and one end with a punched hole for a tubing connection. Both 
the standard method (plasma treatment) and the method using a pre-polymer “glue” layer were 
used for constructing these devices. To perform the motility assay, solutions were pipetted at the 
edge of the device next to the open end of the channel, and a syringe was attached via tubing to 
the other end of the channel. Pulling the syringe plunger back resulted in a vacuum, which pulled 
the solutions through the channel. Solution volumes and incubation times from the standard 
motility assay procedure were used. Both 0.3% methylcellulose and 10 mM DTT were present in 
Glass Surface
PDMS Mold with Channels PDMS 
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the ATP solution. The channel was imaged using fluorescence microscopy after the addition of 
the ATP solution. 
 
 
 
 
 
 
 
Figure 10. Schematic of a modified microfluidic device with an open-ended channel. 
 
Reactions at the Surface of a Microfluidic Device (with Laminar Flow) 
A glass coverslip was cleaned using a plasma cleaner and functionalized with 3-
aminopropyltrimethoxysilane as described above. A PDMS mold with a cross-shaped channel 
pattern was exposed to an air plasma for 20 seconds and bonded to the functionalized glass to 
complete the device. As depicted in Figure 11-A, phosphate buffer was introduced into channels 
2 and 3 at a flow rate of 1.0 mL/hr. Then, 0.01 mg/µL NHS-LC-biotin (an N-
hydroxysulfosuccinimide ester of biotin, which contains an amine-reactive group) in phosphate 
buffer was started flowing in channel 1 at a flow rate of 0.1 mL/hr. The phosphate buffer flow in 
channels 2 and 3 was decreased to 0.2 mL/hr, and the solutions were allowed to flow for 30 
minutes. This setup created a sheath flow beginning at the intersection and exiting out channel 4. 
The biotin flow was stopped, and the device was washed with buffer for 15 minutes at a rate of 
2.0 mL/hr. The remaining surfaces were coated with BSA by introducing a 1.0 mg/mL BSA 
solution into channel 1 and allowing it to flow out of all three other channels for 30 minutes at a 
Modified Microfluidic Device
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rate of 0.1 mL/hr. The BSA blocked non-specific binding of neutravidin-FITC (fluorescein iso-
thiocyanate) to the surface. Channels 1 and 4 were then used as buffer inputs, and the washing 
step was repeated. Next, the buffer flow rate was lowered to 1.0 mL/hr, and 10 µg/mL 
neutravidin-FITC was flowed through channel 3 at a rate of 0.1 mL/hr (Figure 11–B). The buffer 
flow rate was decreased to 0.2 mL/hr, and the solutions were allowed to flow through for 30 
minutes, with all solutions exiting channel 2. The device was then rinsed again with buffer and 
imaged using fluorescence microscopy. 
 
 
 
 
 
 
  
 
 
Figure 11. Experimental design for testing reactions at the surface of a microfluidic device. 
 
Introducing Actin-Myosin System into Microfluidic Device 
To introduce all of the necessary components for the actin-myosin system into the 
microfluidic device, we utilized a six-port injector. In this setup, buffer was flowing from a 
syringe pump into the device continuously. An injection port connected to a sample loop allowed 
the necessary reagents to be injected into the device. HMM was added to the device first, 
followed by BSA, which blocked any surfaces that were not coated by HMM. The actin was then 
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injected and bound to the myosin heads present on the surface. Fluorescent microscopy was used 
to visualize actin filaments bound to the device surface. 
To optimize the conditions for blocking the channels with BSA, fluorescently-labeled 
BSA was introduced into microfluidic channels using various flow rates and exposure times and 
imaged using fluorescence microscopy. The fluorescence signal was interpreted to estimate an 
exposure which saturated the channel floor with BSA. Unlabeled BSA was then introduced to a 
channel using the optimized conditions (30 minutes of exposure to a 1 mg/mL BSA solution at a 
flow rate of 0.02 mL/hr). Actin was then flowed through the channel, and the channel floor was 
imaged using fluorescence microscopy. In another channel, HMM was deposited, followed by 
BSA blocking using the same conditions. Actin was introduced and the channel was imaged. 
Laminar Flow 
 To demonstrate laminar flow, a microfluidic device was set up with three inputs and one 
output channel. Red, blue, and green dye solutions were flowed into three inputs on the device. 
The flow rates were initially set at 0.05 mL/hr. An optical microscope was used for observation.  
 In another experiment, a microfluidic device with the channel pattern shown in Figure 6–
C was constructed. Blue dye was introduced into the middle of the “Y”-shaped portion with 
buffer flowing through the inputs on either side of the dye to create a sheath flow. The result was 
again observed with an optical microscope.  
 
Results and Discussion 
Atomic Force Microscopy of Cleaned Surfaces and Image Analysis 
In our early actin-myosin motility experiments using TMCS-derivatized glass, the glass 
was cleaned with water, ethanol, and isopropanol. Based on several AFM scans, it appeared that 
these surfaces were still quite contaminated. Particles on the surface could interfere with the 
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chemistry of functionalizing the surface, leading to less than optimal results if HMM cannot 
adsorb to the surface in a way that supports motility. Due to this result, a new cleaning method 
was tested, in which glass coverslips were cleaned with piranha solution. Figure 12 shows a 
comparison of two glass surfaces cleaned via the different methods. Comparisons of both the 
scan images and the RMS surface roughness measurements show that far less contamination was 
evident on the glass cleaned with piranha solution. To ensure that the glass was as free of 
contamination as possible, piranha solution was adopted as the primary cleaning method for the 
remainder of the TMCS-coated glass experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. AFM images of glass coverslips cleaned with two different methods. 3D (A) and flat 
(B) representations of a 20x20 µm2 scan of glass cleaned by washing in water, ethanol, and 
isopropanol. Flat (C) and 3D (D) representations of a 20x20 µm2 scan of glass cleaned using 
piranha solution. The images were set to a common z-height range for comparison. The original 
ranges were 83.23 nm for the left image and 9.71 nm for the right image. 
 
Functionalizing the Glass Surface of a Microfluidic Device 
One constraint on our system was the requirement of a surface which would both bind 
myosin and support the motility of actin filaments or bundles. The standard nitrocellulose surface 
could not be used with a microfluidic device because PDMS cannot form an irreversible seal 
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RMS Surface Roughness: 1.13 nm 
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with the glass surface if it is coated with nitrocellulose. Due to the viscosity of the nitrocellulose 
solution, it would be very difficult to flow nitrocellulose through a microfluidic channel and 
leave only a thin coating on the channel walls after it was constructed. Therefore, another 
functionalization method was required to create a surface that supports motility within the 
device.  
We functionalized glass surfaces with either 3-aminopropyltrimethoxysilane or TMCS 
and tested the ability of the modified glass surfaces to both support actin motility and covalently 
bond with plasma-treated PDMS. It was determined that the TMCS-functionalized glass surfaces 
did not form permanent bonds to the PDMS, but the surfaces treated with 3-
aminopropyltrimethoxysilane did. While it would have been convenient to have the ability to 
functionalize the glass prior to device assembly, actin-myosin motility observed during standard 
motility assays was limited on the 3-aminopropyltrimethoxysilane-treated surfaces. Better 
motility was observed on the TMCS-treated surface so TMCS was chosen as the reagent for 
functionalization.  
A disadvantage of using TMCS was the requirement that the device be assembled before 
the glass surface was treated. For this reason, a method for vapor depositing TMCS inside the 
microfluidic channels was developed. A series of myosin-actin motility experiments showed that 
incubating a glass coverslip with TMCS vapor for one hour yielded some motility, but increasing 
the incubation time to four hours yielded motility over a greater area of the treated surface. 
While these large scale test experiments yielded positive results, it was difficult to test the quality 
of the surface inside of a microfluidic channel once the TMCS was deposited. Therefore, we 
could not confirm that a TMS-functionalized surface was being achieved in our device. Vapor 
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deposition was also a very time consuming process. For these reasons, we chose to switch to 
solution deposition of the TMCS.   
By using a solution deposition method to functionalize the glass surface of our 
microfluidic device, it was possible to confirm that TMCS solution was coming in contact with 
the interior of our channels. This method of deposition required finding a solvent for TMCS that 
would be compatible with PDMS. PDMS swells when it comes in contact with many solvents, 
such as pentane, methylene chloride, and toluene. These solvents had to be avoided to prevent 
distortion of our channels. Also, retention of some solvents in the PDMS could be harmful to the 
myosin and actin proteins. When water was used as a solvent, the treated glass appeared to 
maintain its hydrophilicity (based on observation of water surface contact angle), indicating that 
TMCS had not reacted significantly with the hydroxyl groups on the glass. This lack of surface 
functionalization was most likely due to the rapid hydrolysis of TMCS by water, resulting in 
trimethylsilanol. Ethanol proved to be an acceptable solvent, however, with the treated glass 
surface becoming much more hydrophobic. While ethanol could still react with TMCS, it still 
allows functionalization of the glass, especially when higher concentrations of TMCS are used. 
Testing of various concentrations of TMCS in ethanol (1%, 2% and 5%) found that motility was 
most consistent on glass treated with 5% TMCS solution for 15 minutes, so this method was 
chosen as the standard procedure for the remaining experiments. 
Actin Motility Assay in a PDMS/Glass Flow Cell 
One major impediment to achieving and controlling actin translation within a 
microfluidic device is the change in materials needed for a flow cell as opposed to a microfluidic 
device. Since a flow cell is open-ended, it can be easily constructed from two glass surfaces held 
together by something such as double-sided tape. A microfluidic device, however, needs to be 
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sealed so that the fluid being pumped through the channels remains contained. While 
microfluidic devices can be fashioned from glass, it is a difficult and time consuming process. 
Often, the channels are molded using a polymer, because it is much easier than etching 
techniques. PDMS is one polymer that is frequently used. There are many advantages to using 
PDMS for microfluidic applications. It provides good reproducibility of micron-sized features 
and can create seals through the formation of covalent bonds (after treatment with air plasma). It 
is also nontoxic and optically transparent37. However, PDMS is problematic in one respect. It is 
much more permeable to oxygen than is glass. The oxygen permeability of neat PDMS has been 
reported as 800 Barrers (1 Barrer = 10-10 cm3 (STP) · cm (cm2 · s · cm Hg)-1)39. 
Initially, we attempted to use both hydrophilic PDMS surfaces (plasma treated for 40 
seconds) and functionalized PDMS surfaces (plasma treated for 40 seconds and exposed to a 5% 
TMCS solution for 15 minutes) to construct flow cells. Our experiments showed that actin 
motility was achieved in the PDMS/glass flow cells when either 0.3% or 0.6% methylcellulose 
was present in the ATP solution, but only for a short time after illumination (Figure 13). Upon 
illumination, motility quickly ceased. Motility was present on both nitrocellulose-coated and 
TMCS-treated glass. Although motility was limited, these results proved that the proteins 
remained functional after introduction into a cell constructed partially of PDMS. The results 
were similar to other studies where oxygen was cited as an inhibitor of motility30,40,41.  
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0 sec                        2 sec                       4 sec                        6 sec                      8 sec 
Figure 13.  Motility of a rhodamine-labeled actin filament in a PDMS/glass flow cell that had 
not been treated to reduce oxygen permeability. A nitrocellulose surface was used and 0.3% 
methylcellulose was present in the ATP solution. 
 
Nalabotu et al.30 showed that oxidative conditions (removal of both the glucose oxidase-
catalase antioxidant system and the reducing agent DTT) in a standard motility assay flow cell 
caused actin filament motility to cease immediately. This effect was attributed to an oxidative 
modification to the myosin. PDMS has also been shown to inhibit motility of the kinesin-
microtubule biomolecular motor system40,41, and it is thought to be due to the presence of 
oxygen. Brunner et al.40 achieved motility of microtubules on a kinesin-coated surface in a flow 
cell constructed of PDMS and glass when illumination was limited, but upon continuous intense 
illumination (such as that needed for fluorescence microscopy), microtubules were found to be 
very unstable, with disintegration occurring within about 30 seconds. This observation coincided 
with photobleaching of the microtubules. The results were very similar to those encountered 
when a glass flow cell was used without the oxygen scavenging system of catalase and glucose 
oxidase. This similarity suggested that the presence of oxygen in the PDMS system was the 
problem. Kabir et al.41 also found that kinesin-microtubule motility ceased rapidly upon 
illumination when PDMS was present, due to its high oxygen permeability. After development 
of a sealed chamber that placed the flow cell in a nitrogen atmosphere, good motility was 
observed with PDMS. These studies clearly indicate that the permeability of PDMS to oxygen is 
a significant hindrance to achieving motility with a biomolecular motor system.  
5 µm 
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To combat this problem, we established a procedure for eliminating the introduction of 
oxygen into the flow cell. Houston et al.42 showed that the permeability of PDMS to oxygen can 
be reduced by plasma treatment. Reductions in the oxygen permeability coefficient of PDMS 
ranged from 40-80% when argon or oxygen plasmas were used. This decline is due to the 
formation of an oxidized surface layer of SiOx that can be up to 130-160 nm thick43. Due to this 
effect, we chose to treat the surface of the PDMS slab used to make the flow cell with an air 
plasma for an extended period of time (20 minutes). When a motility assay was performed, long-
lasting motility was visualized (Figure 14). Based on the observed fraction of moving bundles, 
the average velocity of movement, and the length of time that the bundles were motile, the 
motility achieved was comparable to standard motility assays with a glass flow cell. This result 
confirmed that the actin motility was being inhibited by the presence of oxygen and that 
extended plasma treatment was able to significantly reduce the permeability of the PDMS to 
oxygen. 
 
 
  
 
        0 sec     15 sec  30 sec          45 sec     60 sec 
Figure 14. Actin bundle motility in a PDMS/glass flow cell with reduced oxygen permeability. 
The PDMS surface of the flow cell was treated with an air plasma for 20 minutes. Motility was 
visualized until significant photobleaching had occurred (an additional 60 seconds from the last 
image of this sequence). 
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Actin Motility Assay in a Modified Microfluidic Device 
 After good quality motility was obtained in the PDMS/glass flow cell, we sought to 
develop a way to use the same principles to obtain motility in a microfluidic channel. Because 
heavily plasma-treated PDMS does not bond well to glass, we needed a way to form a good seal 
between the heavily treated PDMS and glass. To do this, we chose to spin-coat a thin layer of 
PDMS pre-polymer onto a silica wafer, place our heavily plasma-treated PDMS mold 
(containing our channel pattern) down onto the wafer, and lift it away again, leaving a thin film 
of pre-polymer on the surface. The mold was then placed onto a clean glass coverslip and heated 
to allow the pre-polymer to polymerize. During polymerization of the pre-polymer, bonds should 
form to hydroxyl groups on both the PDMS mold and the glass, yielding a sealed device. 
 We used this method of constructing a device to make a modified microfluidic device 
which had channels with one hole punched for tubing access and one open end. In this way, we 
were able to reproduce the standard motility assay flow cell procedure. Solutions were pipetted 
onto the glass surface of the device at the open end of the channel. A syringe was connected via 
tubing to the punched hole and was used to pull the solutions through the channel. The same 
volumes, concentrations, and incubation times were used as in the standard assay. When this 
experiment was performed using 800 µm wide channels, actin motility was obtained (Figures 15, 
16).  
Although plasma treatment did significantly improve the motility in the modified 
microfluidic device, it was not as dramatic an improvement as that of the PDMS/glass flow cell. 
The fraction of motile actin and the duration of motility were still not of the quality of a standard 
flow cell. This outcome suggests that the plasma treatment was not as effective at reducing the 
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oxygen content in the PDMS microfluidic channels as it was for the PDMS surface in the flow 
cell. Reasons for this difference need to be further investigated. 
 
 
 
 
 
             0 sec          10 sec     20 sec          30 sec 
Figure 15.  Actin motility in a PDMS microfluidic channel. Very small, rhodamine-labeled actin 
from a solution of actin bundles moves over small distances during a 30 second period of time. 
PDMS had been plasma treated for 20 minutes to reduce oxygen permeability. The cross-section 
of the channel was 800 µm x 150 µm. 
 
 
 
 
 
           0 sec        10 sec             20 sec         30 sec 
 
Figure 16. Actin bundle motility in a PDMS microfluidic channel over a period of 30 seconds. 
The bundles continued to move for longer than 30 seconds but were not tracked. This channel 
was part of the same device as the channel shown in Figure 15 and was used one day after the 
device had been constructed. 
 
Reactions at the Surface of a Microfluidic Device (with Laminar Flow) 
In our eventual device, HMM motors must be adsorbed to the interior glass surface of the 
device while laminar flow is occurring in the channel, so we needed to show that protein 
adsorption and reactions could occur on the device floor under these conditions. It was also 
convenient to show that these reactions can stay confined to an intersection because intersections 
10 µm 
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could be used to specifically treat certain groups of actin in the future. Patterns created by 
laminar flow in the device were evident for both the NHS-LC-biotin flow and the neutravidin-
FITC flow. This observation suggested that some neutravidin-FITC was nonspecifically bound to 
the glass, even after blocking with BSA, and also that some contamination of the side channels 
did occur. However, the most intense fluorescence from the neutravidin-FITC was detected at 
the intersection (Figure 17), which made the experiment successful by showing that the specific 
biotin-neutravidin reaction did take place at the surface of the microfluidic device. This result 
suggests that we should be able to deposit HMM, BSA, and actin onto the surface of our 
microfluidic device under conditions of laminar flow. Additionally, adding cargo to actin 
filaments or bundles stopped at an intersection should be able to be achieved using laminar flow. 
(For additional information regarding the experimental design planned for adding cargo, see 
Laminar Flow discussion.)  
 
 
 
 
 
 
 
 
 
 
 
Figure 17. Reaction of NHS-LC-biotin and neutravidin-FITC on the glass surface of a 
microfluidic device. NHS-LC-Biotin was reacted with a functionalized glass surface in the 
horizontal channel, and neutravidin-FITC was flowed through the vertical channel. The biotin-
neutravidin reaction occurred most strongly at the intersection. See Figure 11 for the 
experimental setup.  
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Introducing Actin-Myosin System into Microfluidic Device 
When a standard microfluidic device with tubing connections at both ends of the channel 
is used, many parameters must be optimized. When the proteins in the motility assay are added 
to a flow cell (or the modified microfluidic device), they are introduced at very specific 
concentrations and are allowed to incubate with the surface for several minutes. In the standard 
microfluidic device, reagents are constantly flowing through the channel, which means that the 
optimal concentrations of reagents used and exposure times at the surface will need to be altered 
from the standard protocol.  
In order to prove that HMM had been deposited in the channel and that actin was bound 
to myosin and not nonspecifically bound to the channel surfaces, we optimized our conditions 
for blocking the channels with BSA. Fluorescently-labeled BSA was introduced into 
microfluidic channels using various flow rates and exposure times. Experiments determined that 
the channel surfaces were saturated with BSA after 30 minutes of exposure to a 1 mg/mL BSA 
solution at a flow rate of 0.02 mL/hr. Under these optimized conditions, unlabeled BSA was 
introduced to a channel, followed by actin. No actin was seen upon imaging, suggesting that 
BSA was blocking the channel surfaces well. In another channel, HMM was deposited, followed 
by BSA blocking using the same conditions. After actin was introduced, images showed that 
actin was bound to the surface, which suggested that we were successful at depositing HMM on 
the channel surface and binding actin to it. 
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Figure 18. Rhodamine-labeled actin filaments bound to the floor of a microfluidic device. The 
edge of the microfluidic channel is denoted with the white dashed line. To the left, actin 
filaments are present inside the channel. To the right, PDMS is bound to the glass to create the 
channel wall. The device was fabricated using the standard device construction method. 
 
Laminar Flow 
One type of flow that can occur in a microfluidic channel is laminar flow, in which 
individual solutions do not mix, instead forming interfaces within the channel. To further 
understand this concept and to determine what type of control we had over the flow of solutions 
within our microfluidic channels, laminar flow experiments were conducted. We were able to 
determine the conditions necessary to produce laminar flow in a device. Using an optical 
microscope, we imaged three different colored dye solutions flowing into three inputs of a device 
(Figure 19). The inputs converged into one common output, where the three colors could be seen 
exiting the device separate from one another. It was also observed that increasing or decreasing 
the flow rate of one dye respective to the others could change the total width that the dye 
occupied within the channel.   
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Figure 19. Laminar flow in microfluidic channels containing blue (top left), red (bottom left), 
and green (bottom right) dye solutions. The dyes enter through input channels, meet at the 
intersection, and display laminar flow in the output channel. Three parallel flows can be seen in 
the output channel since mixing of the dyes does not occur. 
 
The ability to create laminar flow in our devices enables us to overcome an important 
obstacle in the design of our device. By using the principle of laminar flow to create a protective 
sheath flow (buffer-reagent-buffer), we are able to flow reagents past an intersection, as shown in 
Figure 20. This method should allow us to treat actin bundles stopped in the intersection without 
contaminating all of the actin in the main channel. The protective sheath flow prevents leakage 
of reagents into the orthogonal channel at the intersection. In the future, this experimental design 
will be useful as a means to introduce the reagents necessary to start and stop actin at the 
intersection and to load or unload cargo. 
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Figure 20. A blue dye solution is flowed past an intersection with the help of a sheath flow of 
buffer created using the principle of laminar flow. The horizontal channel represents the main 
channel, containing actin, and the dye solution represents a reagent used to modify the actin.  
The sheath flow prevents the reagent from contaminating the main channel. Channel widths are 
100 µm for the horizontal channel and 200 µm for the vertical channel. 
 
Summary 
 The incorporation of biomolecular motor systems into microfluidic devices is a very 
important achievement in the field of nanotechnology, allowing for the creation of nano-cargo 
transport systems that could be utilized for many different purposes. In this work, we have made 
a great deal of progress towards incorporating the actin-myosin system into a microfluidic 
device. Using atomic force microscopy, we showed that a strong cleaning method (piranha 
solution) achieved a surface with much less variation than one cleaned with water and alcohols. 
This cleaning technique is important in achieving a good TMS monolayer on the glass after 
treatment with TMCS. TMCS-functionalized glass surfaces have been shown to work well for 
use inside of microfluidic devices because solution deposition of the TMCS is easy to perform 
Buffer      Reagent      Buffer 
Direction  
of Flow 
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inside of the microchannels once they are constructed. We have also demonstrated that PDMS 
does typically inhibit motility of the actin-myosin system due to its oxygen permeability. 
However, heavy plasma treatment of the PDMS surface has reduced the permeability enough for 
motility to be obtained.  
 
Future Work 
 There is much future work to be done on this project in order to achieve the nano-cargo 
transport device desired. First, the quality of actin-myosin motility in the PDMS microchannels 
must be improved so that the actin can travel over the distances and for the lengths of time 
necessary to transport cargo. Based on our current results, we will attempt to limit the oxygen 
permeability of the PDMS to a greater extent. A more in-depth study of the plasma treatment 
conditions required to produce good motility will be done, and other procedures for reducing 
permeability will be considered. Once consistent motility is obtained in the modified 
microfluidic device, motility will be attempted in a standard device with the six-port injector and 
syringe pump. The conditions for flow and solution concentrations will have to be optimized for 
this system. 
Also, once good motility is achieved, a method for starting and stopping the filaments 
will be employed. We plan to alternate buffer solutions with and without ATP to control the 
motion of filaments. Eventually, we plan to contain the actin in one main channel, with a 
perpendicular channel forming an intersection with it. By flowing buffer solutions with and 
without ATP across the intersection, actin in the intersection will be controlled, allowing 
eventual loading and unloading of cargo to occur.  
Ways to reversibly load and unload cargo onto functionalized actin filaments will also be 
investigated. A method for functionalizing actin filaments with free thiol groups has already been 
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performed in our lab (Appendix B). This work will be expanded upon in order to attach single-
stranded DNA to the actin in a way that motility can still be achieved. This technique will allow 
cargoes labeled with complementary single-stranded DNA to be attached and carried. 
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Appendix A 
I. Isolation of G-Actin from Acetone Powder/Polymerization of G-Actin to Form F-Actin 
1. Weigh out 0.35 g of acetone powder. 
2. Add 10 mL of 1 mM NaHCO3 in water for 10 minutes with gentle mixing. 
3. Centrifuge for 20 minutes at 4000 rpm and 4°C.  Keep supernatant. 
4. Repeat step 3. 
5. Centrifuge for 1 hour at 40,000 rpm at 4°C.  Keep supernatant. 
6. Add 1/100 volume of 3M KCl and leave on ice overnight. 
7. Centrifuge for 1.5 hours at 40,000 rpm at 4°C.  Keep precipitate. 
8. Wash pellet with imidazole buffer and remove liquid. 
9. Add 200 µL of imidazole buffer and mix heavily to reconstitute pellet. 
10. Centrifuge for 15 minutes at 8000 rpm and 4°C.  Keep supernatant. 
11. Perform Bradford assay to determine protein concentration. 
II. Labeling F-Actin with Rhodamine Phalloidin 
1. Dry 20 µL of 6.6 µM rhodamine phalloidin using a Speed-Vac (approximately 5 
minutes). 
 
2. Add 20 µL of 0.25 mg/mL F-actin and allow the solution to incubate overnight. 
III. Bundling F-Actin with Fascin 
1. Dilute 1.5 mg/mL fascin with Tris buffer to achieve a 0.625 mg/mL fascin concentration. 
2. For a 1:1 (g:g) F-actin: fascin ratio, combine 5 µL of 0.25 mg/mL rhodamine-labeled F-
actin, 2 µL of 0.625 mg/mL GST fascin, and 0.6 µL of 0.3 M KCl. (Ratio of F-actin: 
fascin may have to be altered to achieve suitable bundles.) 
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IV. Bradford Assay for Determining HMM Concentration 
1. Make standard BSA solutions of 0, 200, 400, 600, 800, and 1000 µg/mL by diluting a 
stock BSA solution of 2 mg/mL with imidazole buffer. 
 
2. Mix 3 µL of each standard with 1 mL of Coomassie blue reagent and vortex. Also, take 2 
different 3 µL samples of the HMM solution, mix each with 1 mL of Coomassie blue 
reagent, and vortex. 
 
3. Pour each standard or sample into a plastic UV-visible cuvette. 
4. Using the 0 µg/mL BSA standard as the blank, measure absorbance at 595 nm. 
5. Create a standard curve of BSA concentration vs. absorbance. 
6. Determine protein concentration of the HMM sample by plotting the experimental 
absorbance value on the standard curve.   
 
7. Calculate the average concentration of the two HMM samples.    
V. Standard Motility Assay 
1. Pipette 10 µL of 0.2% collodion in amyl acetate (nitrocellulose) onto a glass coverslip 
and use pipette tip to evenly spread over the surface.  
 
2. Bake nitrocellulose-coated coverslip at about 75°C for 1 hour. 
3. Remove nitrocellulose-coated coverslip from oven and allow to cool for 15 minutes. 
4. Construct flow cell by placing two parallel strips of double-sided tape about 0.5 cm apart 
on a glass slide. Place the nitrocellulose-coated side of the coverslip down on the double-
sided tape. 
 
5. Use a pipette tip to add 8 µL of HMM solution to one side of the flow cell. Allow to 
incubate for 5 minutes. 
 
6. Add 25 µL of 1 mg/mL BSA to the same side of the flow cell used previously. Use a 
Kimwipe to wick the HMM solution through the opposite end of the flow cell. Allow 
BSA solution to incubate for 5 minutes. 
 
7. Wash flow cell by adding 25 µL of imidazole buffer and wicking through with a 
Kimwipe. 
 
8. Add 8 µL of actin solution to flow cell and allow it to incubate for 1 – 5 minutes. (The 
actin solution is made by diluting the 0.25 mg/mL actin filament stock or the prepared 
actin bundle stock with imidazole buffer. Dilutions can range from 1/100 to 1/3000 
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depending on the quality of actin stock and the desired number of filaments/bundles per 
area. Turning the flow cell upside down so that the nitrocellulose-coated surface is 
located on the bottom side can help to achieve actin binding, especially if actin bundles 
are used.) 
 
9. Repeat washing from step 7. 
10. Add 18 µL of ATP solution and wick through flow cell. [ATP solution is made with 
96:1:1:1:1 imidazole buffer: 150 mM ATP: glucose: glucose oxidase: catalase. DTT (10 
mM) and/or methylcellulose (0.3%-0.6%) are sometimes included in the ATP solution.] 
 
11. Image flow cell with a fluorescence microscope to visualize actin motility. 
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Appendix B: Functionalization of Actin 
Procedure  
 N-succinimidyl-S-acetylthiopropionate (SATP), hydroxylamine, Ellman’s reagent and 
biotin HPDP were purchased from Thermo Scientific. Actin filaments or bundles were 
functionalized with thioacetate groups by adding the amine-reactive heterobifunctional 
crosslinker, SATP (Figure 21-1). 1 mg of SATP was added to 20 µL of DMSO, and this solution 
was added to 580 µL of imidazole buffer. 3 µL of this solution was then added to the actin 
filaments and allowed to react for 1 hour on ice. The functionalized actin filaments were placed 
on dialysis overnight in a refrigerator to remove the excess SATP. The thioacetate groups were 
converted to thiol groups by addition of 3 µL of 0.5M hydroxylamine (Figure 21-2), and 
Ellman’s reagent was used to determine thiol concentration using UV-visible spectroscopy. 
Standard motility assay procedures were completed using the functionalized actin filaments to 
determine the effect of functionalization on motility. 
 
Figure 21. Reactions for functionalizing actin with free thiol groups. In reaction 1, SATP adds a 
thioacetate group to amine groups on the protein. Hydroxylamine is added in reaction 2, 
converting the thioacetate group to a free thiol. 
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 Functionalized filaments were also reacted with biotin HPDP and neutravidin-FITC and 
observed using fluorescence microscopy to determine if the thiol chemistry was working 
properly. In a separate experiment, fluorescein-labeled, single-stranded DNA with a modified 
disulfide end was added to functionalized filaments and imaged using an OptiSplit microscope in 
order to determine if the filaments and DNA were co-localized.   
Results and Discussion 
We attempted to functionalize the actin with thiol groups in order to create a means for 
the actin in our device to carry cargo in the future. These thiol groups can be used to perform 
thiol/disulfide exchange reactions in order to load various cargos. Actin filaments were exposed 
to SATP, which can add thioacetate groups to lysine residues. The thioacetate groups can later be 
converted to free thiol groups. After testing various ratios of SATP to NH2 groups of actin, it was 
shown that higher relative amounts of SATP caused degradation of the actin filaments (Figure 
22). This effect is presumably due to changes in electrostatic forces. The primary amines of the 
lysine groups present in the actin filaments should have a +1 charge at physiological pH. A 
neutral charge results when the primary amine groups react with SATP. This change could 
ultimately affect the protein structure and cause it to lose its native conformation, and therefore 
lose its functionality. It appears that there is some balance in the number of amine groups that 
can be functionalized before the actin degrades significantly. Our experiments have shown that a 
1:1 ratio of SATP to NH2 groups is allowable.  
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Figure 22. Actin filaments imaged using fluorescence microscopy with the ratio of SATP to 
NH2 groups increasing from left to right. 
 
 
Once functionalized actin filaments were obtained, it was necessary to test the motility of 
the filaments to make sure that they could still be propelled by HMM. Using standard motility 
procedures, it was observed that motility was obtained with the functionalized filaments after 
deprotection of the thiol groups (Figure 23). 
 
Figure 23.  Motility of functionalized actin filaments with free thiols. 
 
We also needed to show that the desired thiol chemistry could be performed. We chose to 
investigate this question with the commonly used interaction of avidin and biotin molecules. To 
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test the thiol/disulfide exchange reaction, biotin HPDP (containing a disulfide group) was added 
to functionalized actin filaments, attaching the biotin molecule to the filament. A neutravidin 
molecule with a fluorophore attached (neutravidin-FITC) was then introduced to react with the 
biotin. This setup allowed visualization of the rhodamine filaments superimposed with the 
fluorescein fluorophore of neutravidin-FITC to show that the chemistry was working properly. 
However, when this experiment was performed in solution, large aggregations of filaments were 
seen after the neutravidin-FITC was introduced (Figure 24). It was concluded that this effect was 
due to neutravidin having four binding sites for biotin. Therefore, each neutravidin-FITC 
molecule could bind up to four actin filaments, which could also be connected to other filaments 
via other neutravidin molecules. 
 
  
 
 
 
 
 
 
Figure 24.  Aggregations of functionalized actin filaments after the addition of neutravidin-
FITC. 
 
 As a way to carry cargo, we attempted to attach single-stranded DNA to the 
functionalized actin filaments. Disulfide-modified DNA was used so that a thiol-disulfide 
exchange reaction would attach the DNA to the actin. Different fluorophores (fluorescein and 
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rhodamine) were used to label the filaments and the DNA so that they could be detected 
independently. Using an OptiSplit microscope, both fluorophores could be observed 
simultaneously so that co-localization of the filaments and DNA could be observed. 
Superimposable images were obtained (Figure 25), suggesting that DNA did attach to the actin 
filaments. However, motility has not yet been obtained when DNA is attached, which is 
potentially due to overloading of the filaments with DNA. Optimization of this attachment still 
needs to be performed. 
 
 
 
 
 
 
 
 
 
Figure 25. Functionalized actin filaments co-localized with disulfide-modified single-stranded 
DNA. A 10x excess of fluorescent, single-stranded DNA to thiol group was used. The filaments 
were imaged using fluorescence microscopy with OptiSplit technology exciting both the 
fluorescein and rhodamine fluorophores simultaneously. Each channel detects a different 
fluorophore; therefore overlapping images suggest that both fluorophores are on one filament.  
 
 
Fluorescein Rhodamine 
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